Mononucleosis is a viral disease caused by the Epstein-Barr virus (EBV), a member of the herpesvirus family. The main characteristic of this disease is the damage to the lymphatic system, accompanied by enlarged lymph nodes, as well as manifestations of intoxication and damage to the larynx, which can lead to difficulty breathing. The main symptoms include fever, fatigue, sore throat and enlarged spleen. In clinical practice, mononucleosis is most often observed in young people aged 15 to 25 years. There is a direct link between the infection and high levels of antibodies to the Epstein-Barr virus in the blood of patients, which allows for diagnosis.
History of the disease and interesting historical facts
Mononucleosis was first described in the early 20th century. In 1920, the German physician N. Braunstein proposed the term "infectious mononucleosis" to describe clinical symptoms similar to those observed in patients with influenza, but with pronounced changes in the cellular composition of the blood. In the 1960s, research into the Epstein-Barr virus opened a new era in understanding the pathogenesis and mechanism of transmission of the infection. Interestingly, in 1964, the first successful serological diagnosis was carried out, which took a central place in the diagnostic process. Mononucleosis has also been the subject of a number of scientific studies aimed at determining its association with certain types of cancer, such as Burkitt's lymphoma and nasopharyngeal carcinoma.
Epidemiology
According to global statistics, the incidence of mononucleosis varies, but in general, there are 10 to 100 cases of the disease per 100 people per year. Adolescents and young adults are most susceptible to the infection, with a peak incidence between the ages of 15 and 25. Epidemiological studies have shown that more than 90% of the adult population by the age of 30 have serological markers of previous Epstein-Barr infection. The prevalence of the disease can also vary depending on geographic location and social conditions. In developing countries, cases of mononucleosis are recorded at earlier ages due to the increased prevalence of the virus in the population.
Genetic predisposition to this disease
Modern research shows that susceptibility to mononucleosis may be due to both genetic factors and the state of the human immune system. Genetic polymorphisms in immune genes, such as the HLA system genes, may influence the risk of developing the disease. For example, certain alleles associated with HLA class II antigens have been identified to a greater extent in patients with mononucleosis. It has also been confirmed that a weakened immune system, particularly in individuals with hereditary immunodeficiencies, increases the likelihood of clinical manifestation of the disease.
Risk factors for the development of this disease
There are several key risk factors that contribute to the development of mononucleosis, which can be divided into physical and chemical:
- Age: Incidence is highest among adolescents and young adults.
- Immune system status: A weakened immune system, such as from chemotherapy or HIV infection, increases the risk.
- Living conditions: high population density, such as in student dormitories or military camps.
- Contact with sick people: The infection is transmitted through saliva, making close contact, such as sharing eating utensils, dangerous.
Diagnosis of this disease
Diagnosis of mononucleosis is based on a thorough medical history, physical examination, and a series of laboratory tests. The main symptoms include:
- Fever.
- Sore throat.
- Enlarged lymph nodes in the neck.
- Enlarged spleen.
Laboratory tests include:
- Complete blood count to detect atypical mononuclear cells.
- Specific serological tests for the detection of antibodies to the Epstein-Barr virus.
Radiological examinations such as abdominal ultrasound are necessary to evaluate the spleen and liver. Differential diagnosis should be made with infections that have similar clinical manifestations such as pharyngitis, acute hepatitis and lymphogranulomatosis.
Treatment
Treatment of mononucleosis is generally symptomatic and aimed at alleviating the patient's condition. Important aspects are:
- Supportive therapy: bed rest and plenty of fluids to eliminate intoxication.
- Pharmacological treatment: antipyretic and pain-relieving drugs such as paracetamol or ibuprofen to control fever and pain.
- Corticosteroids: used in severe cases with risk of respiratory failure.
- Surgical treatment: rare, but indicated cases of abscess formation in the tonsil area.
List of medications used to treat this disease
The most common medications prescribed for mononucleosis include:
- Paracetamol.
- Ibuprofen.
- Prednisolone (if needed).
Disease monitoring
Monitoring of the patient's condition includes regular monitoring of clinical symptoms, laboratory tests and the patient's general condition.
- Control stages: in the first weeks of illness – weekly examinations, then once a month.
- Prognosis: Most patients recover within 4 to 6 weeks, although signs of fatigue may persist.
- Complications: rare, but may include vomiting, asphyxia in regional lymphadenitis.
Age-related features of the disease
The course of mononucleosis differs in different age groups:
- Children under 5 years of age: the infection is often asymptomatic or mild.
- Adolescents and young adults: more severe symptoms, risk of complications.
- Adults: May have chronic fatigue and more severe disease.
Questions and Answers
- How is Epstein-Barr virus transmitted? The virus is transmitted through saliva, making close contact such as kissing and sharing utensils the main route of transmission.
- Can mononucleosis be prevented? There is currently no vaccine against Epstein-Barr virus, but avoiding close contact with people who are sick can reduce the risk of transmission.
- How long does the recovery period last? Most patients begin to notice improvement within 2-4 weeks, but full recovery may take up to several months.
- What symptoms require immediate medical attention? Difficulty breathing, severe sore throat, high fever, and symptoms suggesting a ruptured spleen require immediate assistance.
- What is the approach to treating chronic fatigue after mononucleosis? A long-term approach is usually required, including lifestyle changes, proper nutrition and physical rehabilitation.
